Format

Send to

Choose Destination
Dermatol Surg. 1998 Sep;24(9):1027-31.

Treatment of xanthelasma palpebrarum with bichloracetic acid.

Author information

1
Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44483, USA.

Abstract

BACKGROUND:

Although many treatment modalities have been described for xanthelasma palpebrarum, no single technique has emerged as dominant.

OBJECTIVES:

Our purpose was to review the various therapeutic modalities for xanthelasma and to assess the efficacy of topical bichloracetic acid.

METHODS:

Thirteen patients with 25 xanthelasma were treated with topical 100% bichloracetic acid. Efficacy was assessed over a follow-up period of 7 months to 10.5 years (average, 64 months).

RESULTS:

Eighty-five percent of patients experienced initial complete clearing, and 72% of their lesions have not required retreatment over an average period of 68 months. Recurrences responded well to repeat treatment. Eighty-three percent of recurrent or poorly responsive lesions were associated with high cholesterol. The most resistant patient had four-lid involvement. Excellent cosmetic results and high patient satisfaction were seen.

CONCLUSIONS:

Topical bichloracetic acid is a viable alternative to other modalities in the management of xanthelasma. Advantages include simplicity, cost-effectiveness, speed, safety, and efficacy.

PMID:
9754092
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center